CYP 2.38% 21.5¢ cynata therapeutics limited

The fact that MSB doesn't own Lonza isn't the problem....

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,551 Posts.
    lightbulb Created with Sketch. 1404
    The fact that MSB doesn't own Lonza isn't the problem. The problem is the number of donors which MSB (and Lonza) need.

    Cymerus needs only one donor. Quality is perfectly uniform.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.